Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer.

× No keyword cloud information.

28 in total

1. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.

Authors: D Zhao; C Pan; J Sun; C Gilbert; K Drews-Elger; D J Azzam; M Picon-Ruiz; M Kim; W Ullmer; D El-Ashry; C J Creighton; J M Slingerland
Journal: Oncogene Date: 2014-08-25 Impact factor: 9.867

2. The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.

Authors: Rajat Banerjee; Elizabeth A Van Tubergen; Christina S Scanlon; Robert Vander Broek; Joel P Lints; Min Liu; Nickole Russo; Ronald C Inglehart; Yugang Wang; Peter J Polverini; Keith L Kirkwood; Nisha J D'Silva
Journal: Mol Cancer Ther Date: 2014-02-25 Impact factor: 6.261

Review 3. Targeted therapy in head and neck cancer.

Authors: S K Kundu; M Nestor
Journal: Tumour Biol Date: 2012-02-29

4. Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner.

Authors: Takahiro Osawa; Noritaka Ohga; Yasuhiro Hida; Kazuko Kitayama; Kosuke Akiyama; Yuichiro Onodera; Manabu Fujie; Nobuo Shinohara; Masanobu Shindoh; Katsuya Nonomura; Kyoko Hida
Journal: Cancer Sci Date: 2012-04-17 Impact factor: 6.716

5. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.

Authors: Joyce T O'Connell; Hikaru Sugimoto; Vesselina G Cooke; Brian A MacDonald; Ankit I Mehta; Valerie S LeBleu; Rajan Dewar; Rafael M Rocha; Ricardo R Brentani; Murray B Resnick; Eric G Neilson; Michael Zeisberg; Raghu Kalluri
Journal: Proc Natl Acad Sci U S A Date: 2011-09-12 Impact factor: 11.205

6. New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab.

Authors: Argirios Moustakas; Teri N Kreisl
Journal: Onco Targets Ther Date: 2010-06-24 Impact factor: 4.147

Review 7. Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer.

Authors: Erin M Bertino; Bhuvaneswari Ramaswamy
Journal: Breast Cancer (Dove Med Press) Date: 2010-05-24

Review 8. Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.

Authors: J Ruan; K Hajjar; S Rafii; J P Leonard
Journal: Ann Oncol Date: 2008-12-16 Impact factor: 32.976

9. Tissue Stiffness and Hypoxia Modulate the Integrin-Linked Kinase ILK to Control Breast Cancer Stem-like Cells.

Authors: Mei-Fong Pang; Michael J Siedlik; Siyang Han; Melody Stallings-Mann; Derek C Radisky; Celeste M Nelson
Journal: Cancer Res Date: 2016-08-08 Impact factor: 12.701

Review 10. Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?

Authors: Alfredo Fucito; Chiara Lucchetti; Antonio Giordano; Gaetano Romano
Journal: Int J Biochem Cell Biol Date: 2007-10-23 Impact factor: 5.085